Moreover, CF and AF could elevate antioxidant and Phase II detoxifying enzyme expression through activating the nuclear translocation of Nrf2, which may be the underlying molecular mechanism for protecting SH-SY5Y cells from TBHP-induced oxidative damage. Here, NFE2L2 is linked to cystic fibrosis.